Blog

Despite having pulled Essure from the market in 2018, Bayer finds itself under scrutiny, yet again, for questionable conduct concerning Essure.

Johnson & Johnson is halting sales of its iconic talc-based baby powder in North America, a product that for generations defined the company's wholesome image. The company faces thousands of lawsuits by patients claiming it caused cancer.

Awareness of the association between Elmiron and significant vision loss is now widespread. How much did Janssen Pharmaceuticals and Johnson and Johnson know of the devastating eye injuries caused by its popular and expensive medication?

Although Essure has been withdrawn from the market, Bayer is required to continue post market safety monitoring and reporting regarding the adverse effects of Essure. Due to the volume of reports gained from social media posts, which Bayer bought upon itself by requiring Plaintiffs to produce such onerous information, Bayer now seeks a variance for complying with its reporting requirements ...

The U.S. Food and Drug Administration announced yesterday that it is requesting Sanofi, the manufacturer of Zantac, to remove and withdraw all prescription and over-the-counter Zantac (ranitidine) drugs immediately from the market

Many patients who currently have or were previously implanted with the Essure Sterilization Device have been diagnosed with autoimmune diseases. These patients incur greater risks from the coronavirus than the general population and should take extra care and precautions during this unprecedented situation.

The first Essure case to be tried in California has been continued until likely the beginning of summer. The case, which was to commence today, will be reset hopefully in the May-June time frame. Frustrated E-sisters anxiously look forward to the trials beginning and seeking justice from Bayer.

Essure cases continue to be filed, but at a slower rate than previous months.

As of December 31, 2019, Essure can no longer be implanted in women. Although women who have been adversely harmed by the device are thrilled by the demise of Essure, they say their battle against Bayer is far from over-not until Justice is served.

The FDA held a two-day panel meeting regarding the adverse events related to metal-containing implants. The panel sought recommendations and solutions for health problems stemming from metal implants including dental amalgam.